Sumatriptan recalls
The FDA has published 6 recalls involving Sumatriptan since 2014. The latest was reported on 15 Jun 2022. Most were for sterility. Mckesson Medical-Surgical Inc. Corporate Office has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls6since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 6 100%Class III 0 0%
Why sumatriptan is recalled
Companies
Brands
By year
All sumatriptan recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Sumatriptan Injection, USP, 6mg recalled by Mckesson Medical-Surgical | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Sumatriptan Succinate Tablets, 100 mg, 9-of- use tablets recalledSumatriptan Succinate | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Sumatriptan Succinate Tablets, 50 mg recalledSumatriptan Succinate | Sun Pharmaceutical Industries | Potency & Assay | Nationwide |
| Drug | CLASS II | Sumatriptan Succinate Tablets, 100 mg recalled | Sun Pharmaceutical Industries | Potency & Assay | Nationwide |
| Drug | CLASS II | Imitrex STATdose System, Imitrex recalled by GlaxoSmithKlineImitrex | GlaxoSmithKline | Sterility | Nationwide |
| Drug | CLASS II | Sumatriptan Succinate Injection recalled by GlaxoSmithKline | GlaxoSmithKline | Sterility | Nationwide |
Should you stop taking Sumatriptan?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.